Kaken Pharmaceutical

Developer of small molecules for the treatment of systemic sclerosis and dermatomyositis

placeBunkyo, Tokyo, Japan calendar_todayFounded 1948 groups1,324 employees language kaken.co.jp

Innovation

15 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport; filing pace slowing. Cited 25 times.

YearFilings
20142
20151
20186
20194
20204
20215
Coming soon